CYP24A1 and secondary hyperparathyroidism: Furthermore, our finding that intestine-specific Cyp24a1 deletion can attenuate secondary hyperparathyroidism in an established model of chronic kidney damage suggests that intestinal CYP24A1 could serve as a therapeutic target in CKD and, potentially, other disorders of mineral homeostasis (Figure 8B).